Search

Your search keyword '"Hepatitis C -- Care and treatment"' showing total 2,415 results
Start Over Descriptor "Hepatitis C -- Care and treatment"
2,415 results on '"Hepatitis C -- Care and treatment"'

1. NephroPlus unveils programme to combat hepatitis C in treating haemodialysis patients

Subjects
Health care reform -- Health aspects, Hepatitis C -- Care and treatment, Pharmaceuticals and cosmetics industries
Abstract

Byline: Our Bureau NephroPlus has launched an innovative and impactful programme to address the challenges of hepatitis C infection in haemodialysis patients, particularly in low-resource settings. This initiative according to [...]

Published
2024

2. Researchers at Asklepios Klinik St. Georg Have Reported New Data on Hepatitis (Relink Strategy In Diagnosed-but-untreated Hepatitis C-positive Patients In Germany: Report From a Single Center: Hepatitis C Relink Project Germany)

Subjects
Medical research, Medicine, Experimental, Hepatitis C -- Care and treatment, Physical fitness
Abstract

2024 AUG 10 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in Liver Diseases and Conditions - Hepatitis. According […]

Published
2024

3. 'I got so much on my plate': Understanding care discontinuity for HIV and HCV among formerly incarcerated persons

Author

Porter, Lauren C., Testa, Alexander, Kozerra, Meghan, Philippon, Cassandra, Remrey, Lizabeth, Bijole, Phyllis, Kattakuzhy, Sarah, Alexander, Carla S., and Rosenthal, Elana

Subjects
Ex-convicts -- Health aspects, Hepatitis C -- Care and treatment, HIV infection -- Care and treatment, Business, Health care industry
Abstract

Objective: To explore barriers to care continuity among formerly incarcerated persons with HIV and/or hepatitis C. Data Sources and Study Setting: We draw on data from semi-structured interviews conducted in 2018-2019 with 30 formerly incarcerated persons and 10 care providers. Data were collected across two clinics in Baltimore, Maryland, and Washington, D.C. Study Design: We recruited participants using a combination of nonprobability sampling techniques. Participants completed closed-ended questionnaires and took part in semi-structured interviews related to treatment barriers and incentives. Data Collection/Extraction Methods: Interviews were transcribed using Express Scribe software and transcriptions were open coded using NVivo 12 software. An iterative process was used to relate and build upon emergent themes in interviews. Principal Findings: Our study illuminates both internal and external barriers to care continuity. The most common external barriers were system navigation and housing instability. Internal barriers consisted of overlapping issues related to mental health, substance use, and feelings of shame and/or denial. Conclusion: An overarching theme is that formerly incarcerated persons with HIV and/or HCV are grappling with numerous challenges that can threaten their health and health care. These barriers are cumulative, intersecting, and reciprocal. KEYWORDS hepatitis-C, HIV, justice-involved populations, mental health, substance use, treatment discontinuity What is known on this topic * There is considerable overlap between segments of the US population that are hard-hit by incarceration, as well as by infection with HIV and HCV. * Incarceration can disrupt treatment for those with HIV, and those who have been incarcerated are less likely to adhere to care. What this study adds * Examination of specific external and internal barriers to the continuity of care among justiceinvolved persons with HIV and/or HCV. * The most common barriers identified were system navigation, housing instability, mental health/substance use, and psychological states related to shame and denial. * An exploration of how continuity of care can be disrupted for those with HCV, as well as those with HIV. * A two-sided account from both care providers and formerly incarcerated individuals regarding challenges adhering to, or providing, treatment for HCV and/or HIV., 1 | INTRODUCTION Incarceration can worsen existing health problems, increase the risk of developing new health problems, and introduce complications with respect to accessing or adhering to treatment. (1-3) However, [...]

Published
2023
Full Text
View/download PDF

4. Reports from Hospital Saint-Antoine Add New Study Findings to Research in RNA Replicase Inhibitors [Feasibility, safety, efficacy and potential scaling-up of sofosbuvir-based HCV treatment in Central and West Africa: (TAC ANRS 12311 trial)]

Subjects
West Africa -- Health aspects, Central Africa -- Health aspects, Hepatitis C -- Care and treatment, Health
Abstract

2024 MAY 25 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New study results on RNA replicase inhibitors have been published. According to [...]

Published
2024

5. Menoufia University Researchers Release New Data on Hepatitis C Virus [Hepatocellular carcinoma in hepatitis C virus patients treated with direct acting antivirals (DAAs) and patients not exposed to DAAs: a large center comparative study]

Subjects
Antiviral agents -- Dosage and administration, Epidemiology -- Research, Hepatoma -- Care and treatment, Hepatitis C -- Care and treatment, Health
Abstract

2024 MAY 25 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on hepatitis C virus have been presented. According to news [...]

Published
2024

6. Guideline Updated for Managing Hepatitis C in Chronic Kidney Disease

Subjects
Chronic kidney failure -- Care and treatment, Medical colleges -- Reports, Hepatitis C -- Care and treatment, Health
Abstract

(HealthDay News) — The Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline on prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease has been updated, according [...]

Published
2024

8. Researchers from Samara State Medical University Describe Research in COVID-19 (Characteristics of lipid metabolism disorders in patients with coronavirus infection-COVID-19 with chronic hepatitis C)

Subjects
Care and treatment, Physiological aspects, Analysis, Coronaviruses -- Physiological aspects -- Analysis, Biochemistry -- Analysis -- Physiological aspects, Infection -- Care and treatment, Hepatitis C -- Care and treatment, Liver -- Physiological aspects -- Analysis, COVID-19 -- Care and treatment
Abstract

2024 NOV 4 (NewsRx) -- By a News Reporter-Staff News Editor at Hepatitis Weekly -- Investigators publish new report on COVID-19. According to news reporting out of Samara State Medical [...]

Published
2024

9. Infected blood scandal: Background, impacts, inquiry outcomes and compensation

Subjects
United Kingdom. Parliament -- Political activity -- International economic relations, Tranexamic acid -- Political aspects, Biological products -- Political aspects, Medium term notes -- Political aspects, Blood transfusion -- Political aspects, Scandals -- Political aspects, Hepatitis C -- Care and treatment, Blood donors -- Political aspects, Business, international
Abstract

London: UK Parliament has issued the following news release: Between 1970 and the early 1990s, over 30,000 NHS patients were given blood transfusions, or treatments made using blood products, which [...]

Published
2024

11. U.S. Lags Behind Other Countries in Hepatitis-C Treatment

Author

Alcorn, Ted

Subjects
Hepatitis C -- Care and treatment, News, opinion and commentary
Abstract

Despite an arsenal of drugs, many Americans are still unaware of their infections until it’s too late. A Biden initiative languishes without Congressional approval. In the 10 years since the [...]

Published
2024

12. Hepatitis C could finally be wiped out in the UK with 'groundbreaking' treatment for deadly disease; Hepatitis C could finally be eliminated in part of the UK thanks to increased rapid testing and a 'groundbreaking' antiviral drugs programme, according to the NHS

Subjects
Homeless persons -- Health aspects, Antiviral agents -- Health aspects, Hepatitis C -- Care and treatment, General interest, News, opinion and commentary
Abstract

Byline: By, Benedict Tetzlaff-Deas England could become the first country in the world to eliminate hepatitis C as a public health threat, NHS officials have said. Investment in rapid-testing technology [...]

Published
2024

13. 2023: Year of Egypt's achievements in health sector

Subjects
Hepatitis C -- Care and treatment, Business, international
Abstract

CAIRO - 30 December 2023: With only hours left for the year 2023 to conclude, Egypt considers 2023 a year of health achievements. In the below lines, et highlights the [...]

Published
2023

14. Study Data from University of Washington Update Understanding of COVID-19 (Colocating Syringe Services, Covid-19 Vaccination, and Infectious Disease Testing: Baltimore ' S Experience)

Subjects
Vaccination -- Health aspects, Urban health -- Health aspects, Medical tests -- Health aspects, Diseases -- Care and treatment -- Maryland, Hepatitis C -- Care and treatment, Coronaviruses -- Health aspects, Pharmaceuticals and cosmetics industries, Health, Science and technology, University of Washington
Abstract

2024 SEP 16 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Vaccine Week -- Data detailed on Coronavirus - COVID-19 have been presented. According to news reporting originating [...]

Published
2024

16. Infected blood scandal: Background, impacts, interim compensation and inquiry outcomes

Subjects
United Kingdom. Parliament -- Political activity -- International economic relations, Tranexamic acid -- Political aspects, Biological products -- Political aspects, Blood transfusion -- Political aspects, Scandals -- Political aspects, Hepatitis C -- Care and treatment, Blood donors -- Political aspects, Business, international
Abstract

London: UK Parliament has issued the following news release: Between 1970 and the early 1990s, more than 30,000 NHS patients were given blood transfusions, or treatments which used blood products, [...]

Published
2024

17. Therapy For Hepatitis C

Subjects
Hepatitis C -- Care and treatment, Business, international
Abstract

Tenders are invited for therapy for hepatitis c therapy for hepatitis c Estimated value excluding VAT: Major organization: UNIVERSITY CLINIC FOR INFECTIOUS AND FEBRILE CONDITIONS SKOPJE Address: Vodnjanska 17 Stadt:Skopje [...]

Published
2024

18. NEW JERSEY HUMAN SERVICES TO EMBED NURSE CARE MANAGERS INTO OUTPATIENT SUBSTANCE USE DISORDER TREATMENT AGENCIES TO ADDRESS CO-OCCURRING HEATH NEEDS

Subjects
New Jersey. Department of Human Services -- Management, Social service, Nursing services, Health planning, Hepatitis C -- Care and treatment, Nurses, Substance abuse -- Care and treatment, Company business management, News, opinion and commentary
Abstract

TRENTON, NJ -- The following information was released by the New Jersey Department of Human Services (DHS): Plan Focuses on Improving Overall Health and Wellbeing of Those Served by the [...]

Published
2024

19. HOW EGYPT WON ITS BATTLE AGAINST HEPATITIS C

Subjects
Public health, Hepatitis C -- Care and treatment, News, opinion and commentary, World Bank Group. World Bank
Abstract

WASHINGTON -- The following information was released by the World Bank: After a public health campaign of just one year, Egypt has effectively eliminated Hepatitis C, the third leading cause [...]

Published
2024

20. State University of New York (SUNY) Buffalo Researcher Has Published New Study Findings on Opioids (Facilitated telemedicine for hepatitis C virus: Addressing challenges for improving health and life for people with opioid use disorder)

Subjects
Telemedicine -- Methods, Hepatitis C virus -- Management, Hepatitis C -- Care and treatment, Company business management, Health
Abstract

2023 SEP 23 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on opioids. According to news reporting out of [...]

Published
2023

21. Recent Findings from University of Toronto Provides New Insights into Hepatitis C Virus (Increasing Treatment Rates for Hepatitis C In Primary Care)

Subjects
Medical research, Medicine, Experimental, Medical personnel -- Training, Primary health care -- Methods, Hepatitis C -- Care and treatment, Health
Abstract

2023 SEP 23 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Research findings on Liver Diseases and Conditions - Hepatitis C Virus are [...]

Published
2023

23. Nurses are the key to a remote prescribing program and increasing hepatitis C treatment access

Author

Jagt, Jana Van Der and Hill, Sonja

Subjects
Patient compliance -- Health aspects, Prescription writing -- Health aspects, Hepatitis C -- Care and treatment, Nurses -- Health aspects, Health, Health care industry, Business, international
Abstract

Since 2016, direct-acting antivirals (DAAs) for treating hepatitis C have been progressively listed on the S85 General Schedule. The current pangenotypic regimens have a short treatment duration, minimal side effects, [...]

Published
2024

24. Department of Emergency Medicine Researcher Targets Hepatitis C Virus (Impact of Direct-Acting Antiviral Therapy on Liver Fibrosis Regression among People with Chronic HCV Infection: Results from a Real-Life Cohort in Patients Who Achieved ...)

Subjects
Fibrosis -- Care and treatment, Antiviral agents -- Testing, Liver diseases -- Care and treatment, Hepatitis C -- Care and treatment, Health
Abstract

2023 MAY 13 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on hepatitis C virus is the subject of a new [...]

Published
2023

25. Data on Hepatitis Detailed by Researchers at Gastroenterology Department [P- 63 Treating Hepatitis C (Hcv) in Addiction Centers in Our Community: Another Step Towards Microelimination]

Subjects
Drug addicts -- Care and treatment, Rehabilitation centers -- Services, Hepatitis C -- Care and treatment, Substance abuse -- Care and treatment, Health
Abstract

2023 APR 15 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on hepatitis is the subject of a new report. According [...]

Published
2023

26. Court decision endangers free preventive care for cancer, HIV, other conditions

Author

Durkin, Erin

Subjects
HIV (Viruses) -- Care and treatment, Medicine, Preventive, Preventive health services, Cancer -- Care and treatment, Hepatitis C -- Care and treatment, General interest, Political science, Patient Protection and Affordable Care Act
Abstract

The ruling is being appealed but millions could be affected by a federal ruling in Texas allowing insurers to charge patients for certain treatments such as screening. A judge's decision [...]

Published
2023

27. Researchers at Khulna University of Engineering and Technology (KUET) Publish New Data on Liver Diseases and Conditions (Multiclass liver disease prediction with adaptive data preprocessing and ensemble modeling)

Subjects
Medical research -- Models, Medicine, Experimental -- Models, Liver diseases -- Care and treatment, Hepatitis C -- Care and treatment, Health, Khulna University of Engineering & Technology
Abstract

2024 JUN 14 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Researchers detail new data in liver diseases and conditions. According to news originating [...]

Published
2024

28. Persistent HIV-controllers are more prone to spontaneously clear HCV: a retrospective cohort study

Author

Dominguez-Molina, Beatriz, Tarancon-Diez, Laura, Milanes-Guisado, Yusnelkis, Genebat, Miguel, Resino, Salvador, Rodriguez, Carmen, Gonzalez-Garcia, Juan, Rallon, Norma, Pernas, Maria, Viciana, Pompeyo, Lopez-Cortes, Luis F., Leal, Manuel, and Ruiz-Mateos, Ezequiel

Subjects
HIV patients -- Physiological aspects, Hepatitis C -- Care and treatment, Immune system -- Health aspects, Hepatitis C virus -- Control, Health
Abstract

Introduction: HIV-controllers have the ability to spontaneously maintain viraemia at low or undetectable levels in the absence of antiretroviral treatment. Furthermore, HIV-controllers seem to have a superior capacity to spontaneously clear hepatitis C virus (HCV) compared to non HIV-controllers. Some of these subjects eventually lose HIV-controller status (transient controllers), whereas some HIV-controllers show a persistent natural HIV control (persistent controllers). We aimed to analyse whether persistent controllers have superior capacity to spontaneously clear HCV compared to transient controllers. Methods: We recruited HIV-controllers from January 1981 up to October 2016 with available antibodies to HCV (anti-HCV) data (n = 744). Factors associated with HIV spontaneous control in relation to HCV status were analysed in persistent and transient HIV-controllers with anti-HCV positive (n = 202 and n = 138 respectively) in comparison with 1700 HCV positive non HIV-controllers recruited from January 1981 up to March 2018, bivariate and multivariate analyses, following a logistic regression model, were applied. In addition, the factors related to the loss and time to lose HIV-controller status were explored (n = 744) using Log rank test and Kaplan-Meier curves, in this case the multivariate analysis consisted in a Cox regression model. Results: A higher frequency of HCV spontaneous clearance was found in persistent HIV-controllers (25.5%) compared to non-controllers (10.2%). After adjusting for potential confounders, as sex, age, HIV transmission risk, [CD4.sup.+] T-cell nadir and time of follow-up, HCV clearance was independently associated with persistent HIV spontaneous control (p = 0.002; OR (95% Cl) = 2.573 (1.428 to 4.633) ), but not with transient spontaneous control (p = 0.119; 1.589 (0.888 to 2.845) ). Furthermore, persistent HIV-controllers were more likely to spontaneously clear the HCV in comparison with transient controllers (p = 0.027; 0.377 (0.159 to 0.893). Finally not to lose or lengthen the time of losing this control was independently associated with HCV spontaneous clearance (p = 0.010; 0.503 (0.297 to 0.850). Conclusions: This study shows an association between spontaneous persistent HIV-control and HCV spontaneous clearance. The study findings support the idea of preserved immune mechanisms in persistent HIV control implicated in HCV spontaneous clearance. These results highlight persistent HIV-controllers but not transient controllers as a good model of functional HIV cure. Keywords: HIV; HCV; HIV-controllers; persistent; transient; HCV spontaneous clearance Additional information may be found under the Supporting Information tab for this article., 1 | INTRODUCTION HIV-controllers are a small group of subjects ( On the other hand, HIV-controllers as a whole seem to have a higher capacity to spontaneously clear hepatitis C [...]

Published
2020
Full Text
View/download PDF

29. Reports from Universiti Sains Islam Malaysia Highlight Recent Research in Hepatitis (Budget impact analysis of two treatment approaches for hepatitis C in Malaysia through the use of voluntary and compulsory licensing options)

Subjects
Medical care, Cost of -- Analysis, Antiviral agents -- Dosage and administration -- Supply and demand -- Licensing, certification and accreditation, Hepatitis C -- Care and treatment, Health
Abstract

2023 MAR 11 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in hepatitis. According to news originating from the [...]

Published
2023

30. Research on Hepatitis Discussed by a Researcher at University of North Texas System College of Pharmacy (Interprofessional Collaboration Between a Clinical Pharmacist and Specialty Physicians to Treat Hepatitis C in an Interdisciplinary Medical ...)

Subjects
Medical cooperation -- Methods, Hepatitis C -- Care and treatment, Health
Abstract

2022 OCT 22 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A new study on hepatitis is now available. According to news reporting [...]

Published
2022

31. Egypt's presidential initiative treated 4M patients with Hepatitis C: Report

Subjects
Hepatitis C -- Care and treatment, Business, international, World Health Organization -- Surveys
Abstract

CAIRO - 12 October 2022: A report issued by the Egyptian Ministry of Health and Population revealed that the recently held World Economic Forum confirmed that Egypt presented a successful [...]

Published
2022

33. 'Depressed' ER Nurse Who Allegedly Gave Patients Hep C Is Finally Charged

Subjects
Hospitals -- Emergency service, Emergency nursing, Hepatitis C -- Care and treatment, Nurses, General interest, News, opinion and commentary
Abstract

A Washington State emergency room nurse accused of infecting at least a dozen people with Hepatitis C has finally been charged with a crime, some five-and-a-half years after the allegations [...]

Published
2023

35. CSL Behring's HEMGENIX (etranacogene dezaparvovec-drlb) demonstrates at three years post-treatment long-term durability, safety and greater bleed protection versus prophylactic treatment in people living with haemophilia

Subjects
Hemophilia -- Care and treatment, Prothrombin complex concentrate -- Safety and security measures -- Analysis, Hepatitis C -- Care and treatment, Business, Chemicals, plastics and rubber industries, Hemgenix (Medication)
Abstract

Global biotechnology leader CSL announced on 11 Dec 2023 the three-year results from the pivotal HOPE-B study confirming continued long-term durability and safety of HEMGENIX (etranacogene dezaparvovec-drlb) following a one-time infusion in people living with haemophilia B. The data showing that a one-time infusion of HEMGENIX offers elevated and sustained factor IX activity levels for years were presented in an oral presentation at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition. HEMGENIX is the first and only gene therapy for the treatment of adults with haemophilia B who currently use factor IX prophylaxis therapy, or have current or historical life-threatening bleeding, or have repeated, serious spontaneous bleeding episodes. The Phase III, open label, single-dose, single arm HOPE-B trial included 54 male participants with severe or moderately severe haemophilia B with or without pre-existing AAV5 neutralizing antibodies. Of the 54 participants who received HEMGENIX, 52 completed three years of follow-up. HEMGENIX produced mean factor IX levels of 41.5 IU/dL at year one, 36.7 IU/dL at year two and 38.6 IU/dL at year three post-treatment. In addition, 94% (51 out of 54) of patients remained free of continuous prophylactic therapy. The three-year data also demonstrated that the mean annualized bleeding rate (ABR) for all bleeds was reduced by 64% during months 7-36 of the study (mean ABR 1.52 vs 4.17 during the lead-in period; p=0.0004), sustaining the same bleed reduction that satisfied the study's primary endpoint. The FDA-approved prescribing information for HEMGENIX shows that ABR for all bleeds was reduced by 54% during months 7-18 of the study. Median bleeds per participant decreased from 2.0 during the lead-in period and remained stable at 0.0 during years one to three. There were no serious adverse events related to treatment with HEMGENIX. HEMGENIX was generally well-tolerated, with most treatment-emergent adverse events (76%) considered mild; 95% of adverse events occurred before six months post-treatment. The most common adverse events were an increase in alanine transaminase (ALT), for which nine (16.7%) participants received supportive care with reactive corticosteroids for a mean duration of 81.4 days (standard deviation: 28.6; range: 51-130 days). In addition to the presentation of the three-year results of the HOPE-B trial, two posters on HEMGENIX were presented evaluating HEMGENIX in patients with comorbidities. The first (Abstract no 2258) assessed HEMGENIX in haemophilia B patients with a history of chronic hepatitis C and hepatitis B infections and the second (Abstract no 2256) investigated those with human immunodeficiency virus (HIV). Additionally, an analysis on the indirect treatment comparison of HEMGENIX and factor IX prophylaxis was recently published in Haemophilia. Original source: CSL Behring, website: http://www.cslbehring.com/, Copyright CSL Behring 2023., research and development; etranacogene dezaparvovec-drlb; haemophilia B treatments; HEMGENIX; [...]

Published
2023

36. PCORI STUDY: TELEMEDICINE TREATMENT FOR HCV IN PEOPLE WITH OPIOID USE DISORDER WAS MORE THAN TWICE AS SUCCESSFUL AS OFFSITE REFERRAL

Subjects
Health care reform, Telemedicine, Hepatitis C virus, Hepatitis C -- Care and treatment, News, opinion and commentary, University at Buffalo
Abstract

BUFFALO, N.Y. -- The following information was released by the University at Buffalo - SUNY: Participants cured of hepatitis C also decreased their opioid use and had minimal reinfections during [...]

Published
2023

38. Egypt treats thousands of Africas from Hepatitis C

Subjects
Hepatitis C -- Care and treatment, Business, international, United Nations. General Assembly
Abstract

CAIRO- 22 September 2022: Thousands of African patients with hepatitis C were treated within the Presidential initiative of eliminating Hepatitis C across the African countries. The patients are from South [...]

Published
2022

39. New Telemedicine Study Findings Recently Were Reported by Researchers at State University of New York (SUNY) Buffalo (High Satisfaction With Patient-centered Telemedicine for Hepatitis C Virus Delivered To Substance Users: a Mixed-methods Study)

Subjects
Patient satisfaction -- Evaluation, Telemedicine -- Patient outcomes, Hepatitis C -- Care and treatment, Health
Abstract

2022 SEP 10 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in Telemedicine. According to news reporting out of [...]

Published
2022

40. Research from Victoria Reveals New Findings on Hepatitis (Care navigation increases initiation of hepatitis C treatment following release from prison in a prospective randomised controlled trial: The C-LINK Study)

Subjects
Prisoners -- Health aspects, Continuum of care -- Evaluation, Hepatitis C -- Care and treatment, Health
Abstract

2022 AUG 20 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on hepatitis is the subject of a new report. According [...]

Published
2022

41. Research on Hepatitis C Virus Published by Researchers at Third Affiliated Hospital (IP-10 Interferes With the Antiviral Response of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection)

Subjects
Ribavirin -- Dosage and administration, Ligands (Biochemistry) -- Physiological aspects -- Health aspects, Interferon alfa-2a -- Dosage and administration, Hepatitis C -- Care and treatment, Viral proteins -- Physiological aspects -- Health aspects, Health
Abstract

2022 AUG 6 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A new study on hepatitis C virus is now available. According to [...]

Published
2022

42. New Hepatitis Findings from University of Buenos Aires Described (Summary of key guidelines for locoregional treatment of HCC in Asia, Europe, South and North America)

Subjects
Hepatitis B -- Care and treatment, Cancer -- Care and treatment, Hepatitis C -- Care and treatment, Physical fitness -- Reports, Health, University of Buenos Aires -- Reports
Abstract

2022 AUG 6 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Research findings on hepatitis are discussed in a new report. According to [...]

Published
2022

44. New Hepatitis C Virus Findings from University of Iceland Described (High Rate of Hepatitis C Virus Reinfection Among Recently Injecting Drug Users: Results From the Trap Hep C Program-a Prospective Nationwide, Population-based Study)

Subjects
Drug addicts -- Care and treatment, Hepatitis C -- Care and treatment, Health
Abstract

2022 JUL 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A new study on Liver Diseases and Conditions - Hepatitis C Virus [...]

Published
2022

48. The Nixon-era roots of today's opioid crisis

Subjects
Hepatitis C -- Care and treatment, Substance abuse -- Care and treatment, Business, Computers and office automation industries, Telecommunications industry
Abstract

Byline: Zoe Adams CORRECTION: An earlier version of this piece incorrectly listed the name of the psychiatrist who established the Narcotics Treatment Administration as Henry DuPont. In reality, his name [...]

Published
2023

49. As hepatitis C proliferates, states lift barriers to treatment

Subjects
United States. Centers for Medicare and Medicaid Services, Medical research -- Health aspects, Medicine, Experimental -- Health aspects, Hepatitis C -- Care and treatment, Law
Abstract

While national efforts to eliminate hepatitis C have faced setbacks because of increased drug use, the impact of COVID-19 and insurance complications, there's a bright spot: Some states are now [...]

Published
2022

50. WHO publishes updated guidance on hepatitis C infection - with new recommendations on treatment of adolescents and children, simplified service delivery and diagnostics

Subjects
Hepatitis C virus -- Health aspects, Infection -- Care and treatment, Hepatitis B -- Care and treatment, Hepatitis C -- Care and treatment, Pharmaceuticals and cosmetics industries
Abstract

Updated WHO Guidance on hepatitis C (HCV) infection was released during a joint WHO-EASL-CDC symposium at the EASL International Liver Congress 2022 in London. These guidelines recommend a radical simplification [...]

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results